Eric A Young - Net Worth and Insider Trading
Eric A Young Net Worth
The estimated net worth of Eric A Young is at least $4.2 Billion dollars as of 2024-05-06. Eric A Young is the 10% Owner of DexCom Inc and owns about 32,650,160 shares of DexCom Inc (DXCM) stock worth over $4.2 Billion. Details can be seen in Eric A Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric A Young has not made any transactions after 2005-11-10 and currently still holds the listed stock(s).
Transaction Summary of Eric A Young
Eric A Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric A Young owns 4 companies in total, including Amicus Therapeutics Inc (FOLD) , EPIRUS Biopharmaceuticals Inc (EPRSQ) , and DexCom Inc (DXCM) among others .
Click here to see the complete history of Eric A Young’s form 4 insider trades.
Insider Ownership Summary of Eric A Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2007-05-30 | 10 percent owner |
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 2005-11-15 | 10 percent owner |
| DXCM | DexCom Inc | 2005-11-10 | 10 percent owner |
 | | 2004-09-10 | director |
Eric A Young Latest Holdings Summary
Eric A Young currently owns a total of 1 stock. Eric A Young owns 32,650,160 shares of DexCom Inc (DXCM) as of November 10, 2005, with a value of $4.2 Billion.
Latest Holdings of Eric A Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DXCM | DexCom Inc | 2005-11-10 | 32,650,160 | 128.92 | 4,209,095,376 |
Holding Weightings of Eric A Young
Eric A Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric A Young has made a total of 0 transactions in DexCom Inc (DXCM) over the past 5 years. The most-recent trade in DexCom Inc is the sale of 16,848,000 shares on November 10, 2005, which brought Eric A Young around $14 Million.
Insider Trading History of Eric A Young
- 1
Eric A Young Trading Performance
Eric A Young Ownership Network
Eric A Young Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Eric A Young is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Eric A Young made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 145,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 145,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Eric A Young Mailing Address
Above is the net worth, insider trading, and ownership report for Eric A Young. You might contact Eric A Young via mailing address: C/o Canaan Partners, 285 Riverside Avenue, Suite 250, Westford Ct 06880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
